PhD
Vision Science, University of California, 2015

MPH
Epidemiology, University of California, Berkeley, 2007

OD
University of California, Berkeley, 2004

BA
Molecular and Cell Biology, University of California, Berkeley, 1999

Metruccio MME, Wan SJ, Horneman H, Kroken AR, Sullivan AB, Truong TN, Mun JJ, Tam CKP, Frith R, Welsh L, George MD, Morris CA, Evans DJ, Fleiszig SMJ (2019). A novel murine model for corneal lens wear reveals clandestine IL-1R dependent corneal parainflamation and susceptibility to microbial keratitis upon inoculation with Pseudomonas aeruginosa. Ocul Surf (1): 119-133.

Wu YT, Truong TN, Tam C, Mendoza MN, Zhu L, Evans DJ, Fleiszig SMJ (2018). Impact of topical corticosteroid pretreatment on susceptibility of the injured murine cornea to Pseudomonas aeruginosa colonization and infection. Exp Eye Res (179): 1-7.

Wang D, Wu F, Yan H, Kang GJ, Truong TN, Chen L, McCallion AS, Gong X, Li S (2017) Sox0+ cells contribute to vascular development in multiple organs-brief report. Artioscler Thromb Vasc Biol. (9):1727-1731.

Kang GJ, Ecoiffier T, Truong TN, Yuen D, Li G, Lee N, Zhang L, Su V, Chen L (2016). Intravital imaging reveals dynamics of lymphangiogesis and valvulogenesis. Sci Rep. 6-19459.

Kang GJ, Truong TN, Huang E, Su V, Ge Shaokui, Chen L (2016). Integrin alpha 9 blockage supressess lymphatic valve formation and promotes transplant survival. Invest Ophthalmol Vis Sci. 16-20130.

Truong TN, Li H, Hong Y,Chen L (2014). Novel characterization and live imaging of Schlemm’s canal expressing Prox-1. PLOSONE. 9(5):e98245.

Yuen D, Grimaldo S, Sessa R, Ecoiffier T, Truong TN, Huang EH, Bernas M, Daley S, Witte MH, Chen L (2014). Role of Ang-2 in corneal lymphangiogenesis. Invest Ophthalmol Vis Sci. 13-13779.

Truong TN, Huang E, Yuen D, and Chen L (2014). Corneal lymphatic valve formation in relation to lymphangiogenesis. Invest Ophthalmol Vis Sci. 13-13351.

Truong TN, Graham AD, Lin MC (2014). Factors in contact lens symptoms: Evidence from a multistudy database. Optom Vis Sci. (2):133-41.

Truong TN, Altiok E, Yuen D, Ecoiffier T, and Chen L (2011). Novel characterization of lymphatic valve formation during corneal inflammation. PLOSONE. 6(7):e21918.

Lin MC, Yeh T, Graham AD, Truong TN, Hsiao C, Louie A (2011). Ocular surface health during 30-day continuous wear: rigid gas-permeable vs. silicone hydrogel hyper-O2 transmitted contact lenses. Invest Ophthalmol Vis Sci. 10-6025.

Graham AD, Truong TN, Lin MC (2009). Conjunctival epithelial flap in continuous contact lens wear. Optom Vis Sci. 86(4):324-31.

Lee EJ, Truong TN, Mendoza MN, Fleiszig SM (2003). A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics. Current Eye Research. 27(5): 289-99.

Hurwitz AA, Foster BA, Kwon ED, Truong TN, Choi EM, Greenberg NM, Burg MB, Allison JP (2000). Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. Cancer Research. 20(9): 2444-8.

Hurwitz AA, Elsas A, Leach DR, Ziskin J, Villasenor J, Truong TN, Allison JP (1999). Manipulation of T-Cell activation to generate anti-tumor CTLs. Cytotoxic Cells: Basic Mechanisms and Medical Applications. p385-394.

Dr. Truong is a clinical research optometrist. His primary research emphasis for the past 20 years include furthering our understanding of basic mechanisms of ocular immunology and developing ophthalmic products for the contact lens and medical device industry. He has a multifaceted and balanced approach to research that is tailored towards translational research. He is known for his creative problem solving and detail-oriented research approach with broad cross-functional training in molecular and cell biology, epidemiology, and vision science. He aspires to integrate the skills and knowledge he has gained to explore new technologies for the diagnosis and treatment of ocular inflammation. He wants to increase the rate at which we apply the ever-increasing knowledge that is constantly being gathered through basic science and clinical research. Teaching at Berkeley, practicing at his private practice, and consulting for the ophthalmic medical device industry are all ways in which he strives to translate basic research into the delivery of patient care.